TIM
ABBV icon

Thornburg Investment Management’s AbbVie ABBV Stock Holding History

Thornburg Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136M Buy
541,146
+38,314
+8% +$8.24M 1.3% 21
2026
Q1 		$109M Buy
502,832
+101,822
+25% +$22.6M 1.14% 23
2025
Q4 		$91.6M Sell
401,010
-750
-0.2% -$171K 1.16% 21
2025
Q3 		$93M Buy
401,760
+81,625
+25% +$16.6M 1.21% 21
2025
Q2 		$59.4M Sell
320,135
-4,706
-1% -$875K 0.76% 30
2025
Q1 		$68.1M Sell
324,841
-487,259
-60% -$94.7M 0.95% 27
2024
Q4 		$144M Sell
812,100
-275
-0% -$50.6K 1.91% 16
2024
Q3 		$160M Buy
812,375
+4,777
+0.6% +$892K 2.09% 14
2024
Q2 		$139M Hold
807,598
– – 1.95% 13
2024
Q1 		$147M Sell
807,598
-197,107
-20% -$34M 2.05% 12
2023
Q4 		$156M Hold
1,004,705
– – 2.25% 13
2023
Q3 		$150M Hold
1,004,705
– – 2.46% 12
2023
Q2 		$135M Buy
1,004,705
+2,000
+0.2% +$293K 2.19% 12
2023
Q1 		$160M Sell
1,002,705
-76,879
-7% -$11.8M 2.64% 9
2022
Q4 		$175M Sell
1,079,584
-307,163
-22% -$47.1M 2.95% 7
2022
Q3 		$186M Sell
1,386,747
-1,243,301
-47% -$178M 3.3% 7
2022
Q2 		$403M Sell
2,630,048
-122,659
-4% -$18.7M 6.17% 2
2022
Q1 		$446M Sell
2,752,707
-724,519
-21% -$105M 5.85% 3
2021
Q4 		$471M Sell
3,477,226
-62,705
-2% -$7.41M 5.52% 3
2021
Q3 		$382M Buy
3,539,931
+116,341
+3% +$13.3M 4.69% 3
2021
Q2 		$386M Sell
3,423,590
-31,178
-0.9% -$3.51M 4.43% 3
2021
Q1 		$374M Buy
3,454,768
+1,889
+0.1% +$202K 4.34% 3
2020
Q4 		$370M Sell
3,452,879
-255,389
-7% -$24.5M 4.39% 4
2020
Q3 		$325M Sell
3,708,268
-27,637
-0.7% -$2.6M 4.29% 4
2020
Q2 		$367M Buy
3,735,905
+289,896
+8% +$25.5M 4.71% 1
2020
Q1 		$263M Buy
3,446,009
+705,697
+26% +$60.1M 3.75% 8
2019
Q4 		$243M Buy
2,740,312
+3,485
+0.1% +$289K 2.33% 12
2019
Q3 		$207M Buy
2,736,827
+1,802,197
+193% +$124M 2% 14
2019
Q2 		$68M Buy
+934,630
New +$73.5M 0.65% 46

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Thornburg Investment Management's ABBV Position: Q2 2026 in Review

Thornburg Investment Management increased its AbbVie (ABBV) stake by 7.6% in Q2 2026, buying an estimated $8.24M and bringing the position to 541,146 shares worth $136M. The position accounts for 1.3% of the portfolio, ranked #21.

Thornburg Investment Management first reported a position in ABBV in Q2 2019 and has held it in 29 quarters since. The position peaked at $471M in Q4 2021. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Thornburg Investment Management held 541,146 shares of AbbVie worth $136M as of Q2 2026.
  • Thornburg Investment Management bought 38,314 AbbVie shares in Q2 2026, an estimated $8.24M.
  • AbbVie made up 1.3% of Thornburg Investment Management's portfolio in Q2 2026, its #21 holding.
  • Thornburg Investment Management first reported a position in AbbVie in Q2 2019 and has held it in 29 quarters since.
  • Thornburg Investment Management's AbbVie position peaked at $471M in Q4 2021.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Thornburg Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.